Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 3.43B | 3.78B | 4.30B | 4.54B | 4.18B | 4.24B |
Gross Profit | 581.83M | 688.97M | 828.72M | 945.40M | 822.92M | 901.90M |
EBITDA | -204.98M | 22.20M | 301.02M | 244.52M | 364.99M | 326.10M |
Net Income | -355.24M | -189.02M | 62.45M | 45.73M | 168.82M | 91.59M |
Balance Sheet | ||||||
Total Assets | 2.54B | 2.62B | 2.98B | 3.50B | 3.74B | 3.96B |
Cash, Cash Equivalents and Short-Term Investments | 134.80M | 150.34M | 288.31M | 180.71M | 395.60M | 735.82M |
Total Debt | 1.34B | 1.32B | 1.38B | 1.88B | 1.92B | 1.99B |
Total Liabilities | 2.07B | 2.00B | 2.13B | 2.78B | 2.90B | 2.96B |
Stockholders Equity | 477.10M | 620.06M | 850.64M | 723.55M | 842.22M | 1.00B |
Cash Flow | ||||||
Free Cash Flow | -148.65M | -67.50M | 234.31M | -61.88M | 76.01M | 258.80M |
Operating Cash Flow | 16.94M | 106.21M | 345.19M | 30.34M | 175.67M | 355.65M |
Investing Cash Flow | -46.89M | -153.34M | 279.17M | -67.03M | -92.36M | -82.00M |
Financing Cash Flow | -53.66M | -80.63M | -563.16M | -120.01M | -401.21M | 207.91M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $1.90B | 15.44 | 12.97% | ― | -7.49% | 10.79% | |
76 Outperform | $1.44B | 33.85 | 7.93% | ― | -14.06% | -65.38% | |
70 Neutral | $1.01B | 36.95 | 2.18% | 1.50% | 47.66% | -75.65% | |
70 Neutral | $4.17B | 38.00 | 6.97% | ― | -1.10% | -57.18% | |
68 Neutral | $660.12M | 24.22 | 4.46% | ― | -2.32% | -21.44% | |
65 Neutral | $2.63B | 16.52 | 15.18% | 3.64% | 2.55% | 45.29% | |
52 Neutral | $529.50M | ― | -56.74% | ― | -15.16% | -1232.39% |
JELD-WEN reported its second quarter 2025 financial results, showing a 16.5% decline in net revenues compared to the previous year, primarily due to decreased core revenues and the divestiture of its Towanda facility. The company experienced a net loss from continuing operations of $22.3 million, with adjusted EBITDA declining significantly to $39.0 million. Despite these challenges, JELD-WEN reinstated its full-year 2025 guidance, projecting revenues between $3.2 to $3.4 billion and adjusted EBITDA of $170 to $200 million, amid ongoing competitive pricing and volume pressures.